Skip to main content
. 2020 Jun 13;9(11):e015594. doi: 10.1161/JAHA.119.015594

Figure 2. Participation of women in pivotal drug trials: prevalence‐corrected estimate.

Figure 2

*Coronary heart disease participation‐to‐prevalence ratio was dependent upon 1 trial, so the 95% CI could not be calculated.